Farxiga Lawsuit Filed Over Permanent Injuries From Flesh-Eating Groin Infection
AstraZeneca faces a growing number of product liability lawsuits over the side effects of Farxiga, indicating that the diabetes drug caused plaintiffs to suffer a serious and potentially life-threatening, flesh-eating infection that attacks the groin and genitals.
In a complaint (PDF) filed late last week in the U.S. District Court for the Southern District of Texas, Michael Bustamante indicates the drug maker knew about the association between Farxiga and the rare form of necrotizing fasciitis of the genitals, known as Fournier’s gangrene, yet withheld information from users and the medical community.
Farxiga is part of a new generation of diabetes drug from a class of medications known as sodium-glucose cotransporter-2 (SGLT2) inhibitors, which also includes Jardiance, Invokana, Invokamet, Xigduo XR and others.
Did You Know? Millions of Philips CPAP Machines Recalled
Philips DreamStation, CPAP and BiPAP machines sold in recent years may pose a risk of cancer, lung damage and other injuries.Learn More
In August 2018, the FDA required drug makers to add new warnings indicating Farxiga and other SGLT-2 inhibitors were linked to an increased risk of flesh-eating groin infections, which attacks the genitals and the surrounding area.
Bustamante indicates he began taking Farxiga in 2018 to help treat his Type 2 diabetes, and was left with permanent injuries that could have been prevented.
“After beginning treatment with Farxiga, and as a direct and proximate result thereof, Plaintiff required extensive medical treatment and suffered debilitating injuries, including, but not limited to, destruction of critical tissue and bodily structures, necrotizing fasciitis of the perineum and genital region, and other injuries the full extent of which are not yet realized,” the lawsuit states. “Plaintiff’s injuries were preventable and resulted directly from Defendants’ failure and refusal to conduct proper safety studies, failure to properly assess and publicize alarming safety signals, suppression of information revealing serious and life-threatening risks, willful and wanton failure to provide adequate instructions and warnings, and willful misrepresentations concerning the nature and safety of Farxiga.”
An analysis of 12 Fournier’s gangrene cases led to the FDA’s safety alert in 2018, after which the agency required new label warnings be added to all drugs belonging to the class, including Invokana, Invokamet, Invokamet XR, Farxiga, Xigduo XR, Qtern, Jardiance, Glyxambi, Synjardy, Synjardy XR, Steglatro, Segluromet and Steglujan. Steglatro was the only drug not linked to a case of flesh-eating genital infection, but the agency is requiring it to carry a label warning anyway.
The agency indicated the infections developed within several months of beginning treatment with one of the drugs and all 12 patients underwent hospitalization and surgery. According to the FDA’s findings, at least one patient died, while others suffered multiple disfiguring surgeries and other complications.
Other Side Effects of Farxiga and Similar Drugs
The flesh-eating genital infection warning was just one of several adverse health risk added to Farxiga and similar drugs since they were first introduced on the market. The previous warnings included kidney failure, diabetic ketoacidosis and amputations (specifically for Invokana). The drugs did not carry warnings for any of those risks when they were first approved by the FDA.
Invokana (canagliflozin) was the first SGLT-2 inhibitor introduced to the market, which was approved in March 2013 and quickly became a blockbuster treatment. The medication works in a unique way, impacting some normal kidney functions to help remove glucose from the body through urine.
In December 2015, the FDA required Johnson & Johnson to add new diabetic ketoacidosis warnings to Invokana and similar drugs, indicating the medications increase the risk of this serious condition, which typically results in the need for emergency treatment to avoid life-threatening injury. Prior to the update, the warnings failed to alert consumers about the importance of seeking immediate medical attention if they experience symptoms like abdominal pain, fatigue, nausea, respiratory problems or vomiting.
In June 2016, the FDA required additional label warnings about the link between kidney risks and Farxiga and other drugs from its class, indicating the medications may increase the risk of acute kidney injury and other severe health problems.
Johnson & Johnson and Janssen faced several thousand other Invokana lawsuits, which allege users and the medical community were not provided adequate warnings at the time the drug was first introduced. The makers of other diabetes drugs from the same class, including Xigduo and Farxiga, have also faced similar lawsuits; though most have been filed against the makers of Invokana.
JoanJuly 27, 2022 at 12:03 pm
Took Farxiga for 4 months. Went to ER they said fourinere gangrene possible in my vaginal area. Put on meds not cleared up. The itching is horrible. This is debilitating
CarolynMay 28, 2022 at 12:55 pm
Started feeling a UTI one evening, was prescribed an oral antibiotic and was taken to the ER less than 24 hours later when my husband discovered i had a fever of 104. I was in the hospital for a week with urosepsis. Several antibiotics later, my doctor came in and told me if this last one didn't work that there was no other treatment. One PICC line and a few weeks of antibiotics later, the infecti[Show More]Started feeling a UTI one evening, was prescribed an oral antibiotic and was taken to the ER less than 24 hours later when my husband discovered i had a fever of 104. I was in the hospital for a week with urosepsis. Several antibiotics later, my doctor came in and told me if this last one didn't work that there was no other treatment. One PICC line and a few weeks of antibiotics later, the infection was finally gone. It lowered my blood sugar, just at price of a hospital stay and $3000/day IV antibiotics. So I guess pick your poison.
DonaldApril 27, 2022 at 12:35 pm
I was on this meds in 2016 and had to be hospital due to my nuts swelling to the size of Mellon and infection. Due to the meds and would like to know that I can do because of it and now I have kendeny problems
ralphApril 17, 2022 at 4:25 am
don't take this medicine,, I have had serious side effects
EarleanNovember 2, 2021 at 12:12 pm
I am so sad because I just woke up one morning very very irritated and I didn’t know why I read up on the medication and now I have a life long problem besides my heart problems
SamOctober 21, 2021 at 8:16 pm
Another case of Fournier's Gangrene after only a month of taking Xigduo - such a devastating, life-changing illness. These meds should be banned! The included warning is NOT adequate for warning of this problem!
EmilioAugust 30, 2021 at 10:21 pm
I recently started taking farixga maybe 2 months now i woke up with itching and soreness in my groin area having difficulties urinated and not being able to pull back foreskin for it's painful and there's weird dark purple coloring on the tip i called my Dr who has yet not returned my call and now I'm reading this is one of the side affects of this drug
DanielJuly 26, 2021 at 12:48 pm
I was taking Farxiga. Ended up with necrotizing faciaitis. Was in the hospital for a week. I gave a 6 inch hole in my bottom. I have a wound vac for who knows how long. I'm off work until this heals. This medication should be taken off the market.
JeffreyJune 5, 2021 at 5:53 pm
I was taking Invokana at the time I had to have my penis amputated. Seen this and wondered if it was part or could have been from the drug. My dr first called it clamiddia and then Squiams cell cancer.
"*" indicates required fields
More Top Stories
The President has signed the Camp Lejeune Justice Act into law as part of a larger package of veterans toxic chemical exposure health care benefits, which will allow those exposed to water contamination while living or serving on the base to file lawsuits against the federal government.
Ahead of the first Zantac lawsuit trials, slated to begin next year, investors sold off Sanofi, GlaxoSmithKline and Pfizer stocks, anticipating massive court losses and costs.
A federal judge has issued a pretrial scheduling order setting the first Nexium kidney damage lawsuit to go before a jury in November.